{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:42:03Z","timestamp":1760812923856,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.trim.2023.101907","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T02:26:57Z","timestamp":1690338417000},"page":"101907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Rituximab-associated PRES in antibody-mediated kidney rejection: A case report"],"prefix":"10.1016","volume":"80","author":[{"given":"Masoud","family":"Etemadifar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyyed-Ali","family":"Alaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elahe","family":"Saffari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehri","family":"Salari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.trim.2023.101907_bb0005","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199602223340803","article-title":"A reversible posterior leukoencephalopathy syndrome","volume":"334","author":"Hinchey","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.trim.2023.101907_bb0010","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1007\/s00415-016-8377-8","article-title":"Posterior reversible encephalopathy syndrome","volume":"264","author":"Fischer","year":"2017","journal-title":"J. Neurol."},{"issue":"10","key":"10.1016\/j.trim.2023.101907_bb0015","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1007\/s12035-015-9560-0","article-title":"Posterior reversible encephalopathy syndrome after transplantation: a review","volume":"53","author":"Chen","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.trim.2023.101907_bb0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.carj.2016.08.005","article-title":"Posterior reversible encephalopathy syndrome: a review","volume":"68","author":"Shankar","year":"2017","journal-title":"Can. Assoc. Radiol. J."},{"issue":"6","key":"10.1016\/j.trim.2023.101907_bb0025","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3174\/ajnr.A0929","article-title":"Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema","volume":"29","author":"Bartynski","year":"2008","journal-title":"AJNR Am. J. Neuroradiol."},{"year":"2022","series-title":"Rituximab","author":"Hanif","key":"10.1016\/j.trim.2023.101907_bb0030"},{"issue":"6","key":"10.1016\/j.trim.2023.101907_bb0035","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1600-6143.2004.00454.x","article-title":"Rituximab as treatment for refractory kidney transplant rejection","volume":"4","author":"Becker","year":"2004","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.trim.2023.101907_bb0040","doi-asserted-by":"crossref","first-page":"642","DOI":"10.6002\/ect.2021.0268","article-title":"Posterior reversible encephalopathy syndrome in organ transplantation","volume":"20","author":"Jeelani","year":"2022","journal-title":"Exp. Clin. Transplant."},{"issue":"5852","key":"10.1016\/j.trim.2023.101907_bb0045","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/bmj.1.5852.507","article-title":"Autoregulation of brain circulation in severe arterial hypertension","volume":"1","author":"Strandgaard","year":"1973","journal-title":"Br. Med. J."},{"issue":"2","key":"10.1016\/j.trim.2023.101907_bb0050","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1055\/s-0031-1277990","article-title":"Posterior reversible encephalopathy syndrome: a review","volume":"31","author":"Feske","year":"2011","journal-title":"Semin. Neurol."},{"issue":"2","key":"10.1016\/j.trim.2023.101907_bb0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0014-4827(03)00354-9","article-title":"Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates and expression of claudin-5 gene in blood-brain-barrier endothelial cells via protein kinase A-dependent and -independent pathways","volume":"290","author":"Ishizaki","year":"2003","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.trim.2023.101907_bb0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mvr.2010.10.004","article-title":"Autocrine and paracrine up-regulation of blood-brain barrier function by plasminogen activator inhibitor-1","volume":"81","author":"Dohgu","year":"2011","journal-title":"Microvasc. Res."},{"issue":"3","key":"10.1016\/j.trim.2023.101907_bb0065","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0014-2999(99)00247-2","article-title":"Effect of cyclosporin a or tacrolimus on the function of blood-brain barrier cells","volume":"372","author":"Kochi","year":"1999","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.trim.2023.101907_bb0070","doi-asserted-by":"crossref","DOI":"10.1097\/MJT.0000000000000270","article-title":"Mycophenolate-induced posterior reversible encephalopathy syndrome","volume":"23","author":"Khajuria","year":"2016","journal-title":"Am. J. Ther."},{"issue":"3","key":"10.1016\/j.trim.2023.101907_bb0075","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s12028-013-9852-z","article-title":"Refractory intracranial hypertension in posterior reversible encephalopathy syndrome","volume":"19","author":"Facchini","year":"2013","journal-title":"Neurocrit. Care."},{"issue":"7","key":"10.1016\/j.trim.2023.101907_bb0080","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.transproceed.2008.07.104","article-title":"Two cases of calcineurin inhibitor-associated reversible posterior leukoencephalopathy syndrome in renal transplant recipients","volume":"40","author":"Akutsu","year":"2008","journal-title":"Transplant. Proc."},{"issue":"9","key":"10.1016\/j.trim.2023.101907_bb0085","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4066\/AMJ.2011.627","article-title":"Rituximab as a possible cause of posterior reversible encephalopathy syndrome","volume":"4","author":"Siddiqi","year":"2011","journal-title":"Australas Med J"},{"issue":"3","key":"10.1016\/j.trim.2023.101907_bb0090","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/ajt.13021","article-title":"A unique case of rituximab-related posterior reversible encephalopathy syndrome in a heart transplant recipient with Posttransplant lymphoproliferative disorder","volume":"15","author":"Jaiswal","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"2","key":"10.1016\/j.trim.2023.101907_bb0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5348\/ijcri-201603-CL-10096","article-title":"Rituximab-related posterior reversible encephalopathy syndrome in HUS patient post kidney transplant","volume":"7","author":"Habli","year":"2016","journal-title":"Int. J. Case Rep. Images."},{"issue":"5","key":"10.1016\/j.trim.2023.101907_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2022-248864","article-title":"Posterior reversible encephalopathy syndrome after first rituximab transfusion for treatment of granulomatosis with polyangiitis","volume":"15","author":"Gong","year":"2022","journal-title":"BMJ Case Rep."},{"issue":"3 Suppl 97","key":"10.1016\/j.trim.2023.101907_bb0105","first-page":"S7","article-title":"Posterior reversible encephalopathy syndrome and systemic vasculitis: report of six cases","volume":"34","author":"Lioger","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.trim.2023.101907_bb0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/1756-185X.13427","article-title":"Rituximab-associated posterior reversible encephalopathy syndrome","volume":"22","author":"Mustafa","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.trim.2023.101907_bb0115","first-page":"387","article-title":"Posterior reversible encephalopathy syndrome (PRES) after kidney transplantation: a case report","volume":"60","author":"Ueda","year":"2014","journal-title":"Hinyokika Kiyo."},{"issue":"1 Suppl 2","key":"10.1016\/j.trim.2023.101907_bb0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/sonc.2002.30156","article-title":"Rituximab: mechanism of action and resistance","volume":"29","author":"Maloney","year":"2002","journal-title":"Semin. Oncol."},{"year":"1999","series-title":"High-Dose Methotrexate plus Rituximab (Anti-CD20) Monoclonal Antibody in the Treatment of Primary CNS Lymphoma","key":"10.1016\/j.trim.2023.101907_bb0125"},{"issue":"10","key":"10.1016\/j.trim.2023.101907_bb0130","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1212\/WNL.0b013e31820f2d94","article-title":"Rituximab monotherapy for patients with recurrent primary CNS lymphoma","volume":"76","author":"Batchelor","year":"2011","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.trim.2023.101907_bb0135","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1038\/s41598-022-08387-7","article-title":"Blood-brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins","volume":"12","author":"Hernandez","year":"2022","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.trim.2023.101907_bb0140","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1034\/j.1399-0012.2003.00071.x","article-title":"Impairment of the blood-brain barrier can result in tacrolimus-induced reversible leucoencephalopathy following heart transplantation","volume":"17","author":"Kaczmarek","year":"2003","journal-title":"Clin. Transpl."},{"issue":"1\u20132","key":"10.1016\/j.trim.2023.101907_bb0145","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jns.2009.10.009","article-title":"Central nervous system inflammatory demyelination after rituximab therapy for idiopathic thrombocytopenic purpura","volume":"288","author":"St\u00fcbgen","year":"2010","journal-title":"J. Neurol. Sci."},{"issue":"8","key":"10.1016\/j.trim.2023.101907_bb0150","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/RHU.0000000000000756","article-title":"Autoimmune sequelae following rituximab therapy: a review of the literature and potential immunologic mechanisms","volume":"24","author":"Kersh","year":"2018","journal-title":"J. Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.trim.2023.101907_bb0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.kint.2016.11.029","article-title":"Capillary leak syndrome: etiologies, pathophysiology, and management","volume":"92","author":"Siddall","year":"2017","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.trim.2023.101907_bb0160","first-page":"56","article-title":"Cytokine release syndrome. J Immunother","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"Cancer."},{"issue":"8","key":"10.1016\/j.trim.2023.101907_bb0165","doi-asserted-by":"crossref","DOI":"10.1093\/omcr\/omz072","article-title":"Rare but not beyond care: a young female with altered mental status and seizures","volume":"2019","author":"Pathireddy","year":"2019","journal-title":"Oxf. Med. Case Reports."},{"issue":"18","key":"10.1016\/j.trim.2023.101907_bb0170","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1212\/WNL.0b013e3181dc1af3","article-title":"Posterior reversible encephalopathy syndrome after rituximab infusion in neuromyelitis optica","volume":"74","author":"S\u00e1nchez-Carteyron","year":"2010","journal-title":"Neurology."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327423001247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327423001247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:04:37Z","timestamp":1760810677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327423001247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":34,"alternative-id":["S0966327423001247"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2023.101907","relation":{},"ISSN":["0966-3274"],"issn-type":[{"type":"print","value":"0966-3274"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rituximab-associated PRES in antibody-mediated kidney rejection: A case report","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2023.101907","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101907"}}